Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFUSE-AT 1A: Hylenex-facilitated SC Fluid Administration
NCT01116102Phase 4Terminated
- Sponsor
- Baxter
- Start
- May 2010
- Primary completion
- May 2010
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human hyaluronidase PH20 in dehydration (8 arms), sponsored by Baxter. Primary endpoint: Maximum Measured In-line Fluid Pressure. Started May 2010; status: terminated.
02
Drugs
recombinant human hyaluronidase PH20
03
Conditions
dehydration
Beyond the preview
Go deeper on NCT01116102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116102.